专业服务
英国知识产权局的意见
英国知识产权局提供意见服务，允许利益相关方要求英国知识产权局的审查员说明英国专利或在英国生效的欧洲专利是否有效和/或被特定行为侵犯。英国知识产权局的目标是在大约3个月内发布意见，而且征求意见的成本相对较低。这意味着意见服务提供了一个快速和低成本的方式来获得关于英国或欧洲专利的有效性和/或侵权的官方意见。
要请求英国知识产权局的意见，有必要将寻求意见的问题（有效性或侵权）、请求者对该问题的立场以及该立场所依据的证据通知英国知识产权局。然后，英国知识产权局将公布该请求，以便包括专利所有人在内的第三方（如果所有人不是请求意见的一方）可以在4周内提交意见作为答复。然后，申请人将收到任何提交的意见的通知，并将被给予进一步的2周时间来提出回应意见。然后，英国知识产权局将在不久之后发布其意见。
对于那些希望不向专利所有人披露其身份的客户，您可以通过施利希的名义请求意见来保持匿名。
此外，如果英国知识产权局审查员发现英国（或欧洲）专利无效，并且英国知识产权局对这一结论有足够的信心，英国知识产权局可以（酌情）撤销英国专利（或英国对欧洲专利的指定），从而避免在英国法院进行昂贵的撤销诉讼。
尽管英国知识产权局的意见服务有着明显的价值和优势，但它常常被知识产权客户忽视。每年请求的意见通常不到30份。施利希团队有直接征求英国知识产权局意见的经验，很乐意与您合作，就您感兴趣的专利请求咨询意见。
专业服务
英国知识产权局听证会
英国专利申请的审查可能涉及英国知识产权局听证会官员的听证会。在商标异议结束时，以及在专利或专利申请的所有权和/或权利存在争议的情况下，都可以在英国知识产权局举行听证会。
无论听证会的原因是什么，至关重要的是要仔细、清晰地陈述和论证最佳案例，并与最新的法律和程序紧密结合。我们可以亲自在听证会上代理这些案件。重要的是，我们知道在什么时候可以直接与专业律师合作。
我们还提供关于战略、前景和成本听证会前的建议，以应对所有可能发生的情况。
近期案例解析
阅读来自施利希团队最近与知识产权局相关的案例解析和知识产权局的最新动态。
UK to Second Medical Use SPCs: Thanks, But No Thanks
Background of Supplementary Protection Certificates (SPCs) SPCs are heavily relied on by pharmaceutical companies to extend the period of patent protection. Under the current regulations, SPCs can only be granted if the product is: 1) protected by a basic patent in force; 2) a marketing authorisation has been issued to place that product on the […]
What’s next for Halloumi Producers after their High Court Grilling?
The Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi, recently lost their latest Appeal in the High Court. What are their next steps for protecting their rights?
Court of Appeal uphold majority of Tesco vs Lidl Appeal
The Court of Appeal upheld the decision in relation to passing off and trade mark infringement but did make some comments on the trial judge’s “surprising” findings of fact.
The UKIPO confirms that an SPC is for the product in the marketing authorisation on which it is based and not further uses for the product
It is well known that a pharmaceutical product can find alternative uses than the application for which it was originally developed. Furthermore, further patents can be granted to additional usage and dosage regimes for such pharmaceutical products. The question considered by the Hearing Officer in this case was whether a marketing authorisation for a single active compound (safinamide) was also sufficient to support a supplementary protection certificate (SPC) application for the use of safinamide in combination with levodopa/PDI for the treatment for Parkinson’s disease.
Excluded subject matter: a matter of opinion?
The UKIPO has recently confirmed it can consider excluded subject matter when issuing an Opinion on the validity of a UK patent under Section 74A of the Patents Act 1977.
UK Court Has Jurisdiction to Grant Interim Injunction Before Formal Granted Patent
The UK Courts have decided that they have jurisdiction to grant an interim junction, restraining an infringer, before a European Patent has granted, in the specific circumstances where the Appeal Board of the EPO had held that a patent should be granted, but the formal procedure for grant had not yet been completed.
Extensions of Time Limits due to COVID-19 Disruption
The information in this article is believed to be correct at the time of writing (1 May 2020). Please visit the EPO, UKIPO and EUIPO websites that are being continually updated for the most up-to-date information: EPO: https://www.epo.org/news-issues/covid-19.html UKIPO: https://www.gov.uk/government/news/coronavirus-important-update-on-ipo-services EUIPO: https://euipo.europa.eu/ohimportal/en EPO On 1 May 2020, the EPO published an updated Notice concerning disruptions […]
联系我们
我们的英国和欧洲专利律师和特许商标律师团队具有丰富的知识和经验，能够协助客户满足其知识产权各个方面的法律需求。
立即联系我们，了解我们如何帮助您和您的企业的更多信息。
